-

IFF Announces Dr. Casper Vroemen to Succeed Dr. Gregory Yep as Chief R&D and Sustainability Officer

Vroemen—currently VP of R&D, Health & Biosciences— brings a track record of R&D leadership and commercial success to IFF’s Executive Leadership Team

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announces that Dr. Gregory Yep, Chief R&D and Sustainability Officer, has resigned effective Sept. 1 to pursue a new opportunity in his professional journey. Yep will be succeeded by Dr. Casper Vroemen—Vice President of R&D, Health & Biosciences—who has dedicated his career to the advancement and commercialization of leading-edge biotechnology. Vroemen will be based in Union Beach, New Jersey, and will become part of IFF’s Executive Leadership Team.

“Through Greg’s leadership, we have established IFF as the go-to partner for science-backed solutions for the health, fragrance, nutrition and home and personal care markets,” said Frank Clyburn, IFF CEO. “We thank Greg for his many contributions, and wish him well in his future endeavors. We have a strong successor in Casper, who will continue to advance our innovation pipeline and sustainability efforts.”

Vroemen joined the Company in 2004 as a scientist and project leader. Over the past two decades, he has assumed roles of increasing responsibility in research and development in Europe and the U.S., and has played a major role in establishing IFF as a bioscience powerhouse. During his tenure, he oversaw the company’s leading position in the protein engineering of industrial enzymes, contributed to the commercialization of multiple new technological advancements, and is a prolific inventor named on many patents.

As Chief R&D and Sustainability Officer, Vroemen will further IFF’s efforts in innovation, leading the company’s global R&D strategy, technological development, innovation pipeline and external collaborations. Vroemen holds a Master’s of Science in Molecular Life Sciences and a doctorate in Molecular Biology, both from Wageningen University in the Netherlands.

Welcome to IFF

At IFF (NYSE: IFF)—an industry leader in food, beverage, scent, health and biosciences—science and creativity meet to create essential solutions for a better world. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.

© 2023 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Contacts

Media Relations:
Paula Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

IFF

NYSE:IFF

Release Versions

Contacts

Media Relations:
Paula Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

More News From IFF

Tastepoint by IFF Predicts Ten Flavor Trends for 2026

PHILADELPHIA--(BUSINESS WIRE)--Tastepoint by IFF (NYSE: IFF), a leader in innovative flavor creations and taste solutions, has identified ten flavors expected to shape the North American food and beverage landscape in 2026. These predictions spotlight flavors anticipated to trend in retail, food service and beyond throughout the coming year. “To continue delivering product development solutions that meet consumers’ unique and changing needs, we stay attuned to industry and market trends, keepin...

IFF to Release Fourth Quarter & Full Year 2025 Results on Feb. 11, 2026; IFF to Present at 2026 CAGNY Conference on Feb. 19, 2026

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2025 earnings results following the market close on Wednesday, Feb. 11, 2026. The management team will host a live webcast on Thursday, Feb. 12, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company’s management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 19, 2026 at 1:0...

IFF Introduces Smart Dosing Robot to Transform Fragrance Production

CHIN BEE, Singapore--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences, has implemented the Colibri robot in its Chin Bee production facility. This advanced industrial dosing system can produce fragrance sample batches on demand in minutes, reimagining and expediting the fragrance development journey for local, regional and global customers in Greater Asia. The new robotic system, installed at the company's cross-category Scent a...
Back to Newsroom